Literature DB >> 2828550

Characteristics of phorbol ester- and agonist-induced down-regulation of astrocyte receptors coupled to inositol phospholipid metabolism.

B Pearce1, C Morrow, S Murphy.   

Abstract

We have examined some of the characteristics of phorbol ester- and agonist-induced down-regulation of astrocyte receptors coupled to phosphoinositide metabolism. Our results show that preincubation of [3H]inositol-labelled astrocyte cultures with phorbol 12-myristate 13-acetate (PMA) resulted in a time- (t 1/2, 1-2 min) and concentration-dependent (IC50, 1 nM) decrease in the accumulation of [3H]inositol phosphates (IP) evoked by muscarinic receptor stimulation. Much longer (30-40 min) preincubation periods with higher concentrations (IC50, 600 microM) were required to elicit the same effect with the receptor agonist carbachol. Following preincubation, agonist-stimulated [3H]IP accumulation recovered with time; in both cases pretreatment levels of inositol lipid metabolism were attained within 2 days. Both phorbol ester and agonist pretreatments were also effective in reversing the carbachol-evoked mobilisation of 45Ca2+ in these cells. However, their effects on phosphoinositide metabolism were found not to be additive. Although neither pretreatment affected the incorporation of [3H]inositol into phosphoinositides, both resulted in a loss of membrane muscarinic receptors as assessed by [3H]N-methylscopolamine binding. In washed membranes prepared from [3H]inositol-labelled cultures, the guanine nucleotide analogue, guanosine 5'-O-thiotriphosphate (GTP-gamma-S), caused a dose-dependent increase in [3H]IP formation. This response was enhanced when carbachol was also included in the incubation medium, although the agonist alone was without effect. Pretreatment with either PMA or carbachol had no effect on GTP-gamma-S-stimulated [3H]IP accumulation but did reduce the ability of carbachol to augment this response. Similar findings were obtained when membranes were exposed directly to PMA.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2828550     DOI: 10.1111/j.1471-4159.1988.tb03002.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  7 in total

1.  Phosphoinositide hydrolysis is not negatively regulated by protein kinase C in the peripheral tissues of rat and chick.

Authors:  S V Bhave; R K Malhotra; T D Wakade; A R Wakade
Journal:  J Physiol       Date:  1990-06       Impact factor: 5.182

2.  Contrasting effects of phorbol ester and agonist-mediated activation of protein kinase C on phosphoinositide and Ca2+ signalling in a human neuroblastoma.

Authors:  G B Willars; R A Challiss; J A Stuart; S R Nahorski
Journal:  Biochem J       Date:  1996-06-15       Impact factor: 3.857

3.  Muscarinic M1 receptors activate phosphoinositide turnover and Ca2+ mobilisation in rat sympathetic neurones, but this signalling pathway does not mediate M-current inhibition.

Authors:  E del Río; J A Bevilacqua; S J Marsh; P Halley; M P Caulfield
Journal:  J Physiol       Date:  1999-10-01       Impact factor: 5.182

4.  Characterization of noradrenaline-stimulated cyclic GMP formation in brain astrocytes in culture.

Authors:  L Agulló; A García
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

5.  Effect of phorbol ester on phosphoinositide hydrolysis and calcium mobilization in cultured canine tracheal smooth muscle cells.

Authors:  C M Yang; T C Sung; R Ong; J T Hsieh; S F Luo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-07       Impact factor: 3.000

6.  Regulation of muscarinic receptor function in developing oligodendrocytes by agonist exposure.

Authors:  Eduardo Molina-Holgado; Amani Khorchid; Hsueh-Ning Liu; Guillermina Almazan
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

7.  Desensitization of prostaglandin F2 alpha receptor-mediated phosphoinositide hydrolysis in cultured rat astrocytes.

Authors:  M Gotoh; J Kitanaka; Y Hirasawa; K Kondo; A Baba
Journal:  Neurochem Res       Date:  1994-06       Impact factor: 3.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.